Establishment of ArtemisShield Animal Health Co., Ltd.
On April 1, 2022, ArtemisShield Animal Health Co., Ltd. was officially established. The company primarily focuses on conducting viral vector vaccine R&D and aims to establish itself as a top-notch innovative animal vaccine enterprise.
2022.5.14
ArtemisShield celebrated the opening ceremony of its new laboratory in Guangzhou
On May 14, 2022, ArtemisShield celebrated the opening ceremony of its new laboratory in Guangzhou, signifying the start of both a trial phase and research and development activities.
2022.12
ArtemisShield created a platform for vector vaccines
In December 2022, ArtemisShield created a platform for vector vaccines and formulated a reverse genetics system for operating a range of viral vectors, such as Coronaviruses, Adenoviruses, Herpesviruses, and Parainfluenza viruses.
2023.12
ArtemisShield's R&D expertise had significantly advanced
With the expansion of the talent team, the company is establishing a learning organization. In December 2023, ArtemisShield's R&D expertise had significantly advanced, by focusing on promoting the high-priority R&D pipelineswith outstanding outcomes.
2022.4.1
Establishment of ArtemisShield Animal Health Co., Ltd.
2022.5.14
ArtemisShield celebrated the opening ceremony of its new laboratory in Guangzhou
2022.12
ArtemisShield created a platform for vector vaccines
2023.12
ArtemisShield's R&D expertise had significantly advanced
EN
Location ：Home > About Artemisshield > Development Mil... 